[Genetic heterogeneity of hypertrophic cardiomyopathy in Japanese]

M Machida1

  • 1Department of Cardiovascular Medicine, Hokkaido University School of Medicine, Sapporo, Japan.

[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science
|July 1, 1994
PubMed

Insights

Genetic analysis of Japanese hypertrophic cardiomyopathy (HCM) revealed limited missense mutations in the beta-myosin heavy chain (beta-MHC) gene. These findings suggest different genetic causes for HCM in Japanese versus Caucasian populations.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Human Genetics

Background:

  • Familial hypertrophic cardiomyopathy (FHCM) is often linked to beta-myosin heavy chain (beta-MHC) gene mutations in Caucasian populations.
  • Previous studies suggest a distinct genetic linkage for Japanese FHCM, associated with DNA marker PALB on chromosome 18q.

Purpose of the Study:

  • To investigate the etiological significance of beta-myosin heavy chain (beta-MHC) gene mutations in Japanese hypertrophic cardiomyopathy (HCM) patients.
  • To identify sequence variations in exons 3-25 of the beta-MHC gene in Japanese FHCM kindreds and sporadic patients.

Main Methods:

  • Polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) was employed to analyze beta-MHC gene sequences.
  • Linkage analysis was performed using DNA markers F13B (chromosome 1q) and D11S916 (chromosome 11p-q).

Main Results:

  • Only one missense mutation (codon 741) was identified in a single Japanese FHCM kindred.
  • Two synonymous mutations were found in another kindred, with one also present in a sporadic patient.
  • Statistically negative linkage was observed with markers F13B and D11S916, suggesting they are not primary causes in these families.

Conclusions:

  • The beta-myosin heavy chain (beta-MHC) gene mutations are less prevalent in Japanese HCM patients compared to Caucasians.
  • Multiple causative genes likely contribute to HCM in the Japanese population.
  • The primary genetic determinants of HCM in Japanese individuals appear to differ from those in Caucasian populations.

Related Concept Videos

Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...